4/A
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000899243-21-031614
Director bought 1,625,000 shares at $8.00 ($13,000,000)
- Director acquired 1,232,910 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Manning Paul B · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-29 | Conversion : show line 1 in the form | +679,158 | 679,158 | I | ||
| 2021-07-29 | Conversion : show line 2 in the form | +553,752 | 553,752 | I | ||
| 2021-07-29 | Purchase : show line 3 in the form | +1,625,000 | $8.00 | $13,000,000 | 1,681,000 | D |
| Open-market purchases · 1,625,000 sh · avg $8.00 · $13,000,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-29 | Conversion : show line 4 in the form Series B Preferred Stock | −1,669,303 | 0 | I |
| 2021-07-29 | Conversion : show line 5 in the form Series B Preferred Stock | −1,361,069 | 0 | I |
Loading xslF345X03/doc4a.xml…